ZA95463B - Use of interleukin-12 to prevent graft-versus-host disease - Google Patents

Use of interleukin-12 to prevent graft-versus-host disease

Info

Publication number
ZA95463B
ZA95463B ZA95463A ZA95463A ZA95463B ZA 95463 B ZA95463 B ZA 95463B ZA 95463 A ZA95463 A ZA 95463A ZA 95463 A ZA95463 A ZA 95463A ZA 95463 B ZA95463 B ZA 95463B
Authority
ZA
South Africa
Prior art keywords
interleukin
versus
host disease
prevent graft
prevent
Prior art date
Application number
ZA95463A
Other languages
English (en)
Inventor
Megan Sykes
Stanley F Wolf
Original Assignee
Genetics Inst
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst, Gen Hospital Corp filed Critical Genetics Inst
Publication of ZA95463B publication Critical patent/ZA95463B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA95463A 1994-01-21 1995-01-20 Use of interleukin-12 to prevent graft-versus-host disease ZA95463B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/186,529 US5573764A (en) 1994-01-21 1994-01-21 Use of interleukin-12 to prevent graft versus host disease

Publications (1)

Publication Number Publication Date
ZA95463B true ZA95463B (en) 1995-09-27

Family

ID=22685309

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA95463A ZA95463B (en) 1994-01-21 1995-01-20 Use of interleukin-12 to prevent graft-versus-host disease

Country Status (14)

Country Link
US (2) US5573764A (xx)
EP (1) EP0739212B1 (xx)
JP (1) JP3825043B2 (xx)
AT (1) ATE215380T1 (xx)
AU (1) AU698410B2 (xx)
CA (1) CA2181568C (xx)
DE (1) DE69526206T2 (xx)
DK (1) DK0739212T3 (xx)
ES (1) ES2179096T3 (xx)
IL (1) IL112373A (xx)
PT (1) PT739212E (xx)
TW (1) TW349021B (xx)
WO (1) WO1995019786A1 (xx)
ZA (1) ZA95463B (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573764A (en) * 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
WO1996024369A1 (en) * 1995-02-06 1996-08-15 Genetics Institute, Inc. Formulations for il-12
AU7482696A (en) * 1995-11-01 1997-05-22 Genetics Institute Inc. Methods for administration of il-12
WO1998017814A2 (en) * 1996-10-18 1998-04-30 Valentis Inc. Gene expression and delivery systems and uses
JP2001503257A (ja) * 1996-10-18 2001-03-13 バレンティス・インコーポレーテッド Ｉｌ―１２遺伝子発現および送達系および使用
WO1998034635A1 (en) * 1997-02-07 1998-08-13 The Wistar Institute Methods and compositions for the inhibition of interleukin-12 production
DE69825395T2 (de) * 1997-05-16 2005-01-13 Toray Industries, Inc. Medikament, behandlungsmethode, prophylaktikum und prophylaxe gegen immunologische erkrankungen von hunden und katzen
EP1516630A3 (en) * 1997-10-31 2006-05-03 Wyeth Use of anti-il-12 antibodies in transplantation rejection
US6080399A (en) * 1998-04-23 2000-06-27 Arch Development Corporation Vaccine adjuvants for immunotherapy of melanoma
US7115712B1 (en) * 1999-12-02 2006-10-03 Maxygen, Inc. Cytokine polypeptides
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
WO2003004625A1 (en) * 2001-07-02 2003-01-16 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Methods of generating human cd4+ th2 cells and uses thereof
US7718196B2 (en) * 2001-07-02 2010-05-18 The United States Of America, As Represented By The Department Of Health And Human Services Rapamycin-resistant T cells and therapeutic uses thereof
WO2003038062A2 (en) * 2001-10-31 2003-05-08 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Generation of use of tc1 and tc2 cells
AU2002336417A1 (en) * 2001-08-31 2003-03-18 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Methods of generating human cd4+ th1 cells
DE10248141B4 (de) * 2002-10-11 2007-04-19 Universitätsklinikum Hamburg-Eppendorf Nukleinsäuren und deren Verwendung für die Gentherapie
US7939058B2 (en) 2003-07-03 2011-05-10 University Of Southern California Uses of IL-12 in hematopoiesis
RU2484132C2 (ru) * 2007-10-08 2013-06-10 Интрексон Корпорейшн Модифицированные дендритные клетки и их применение в лечении злокачественных опухолей
US20100272863A1 (en) * 2009-04-24 2010-10-28 Griebel Jonathan M Soft shaped tortillas
US9878012B2 (en) 2010-05-18 2018-01-30 Neumedicines, Inc. IL-12 formulations for enhancing hematopoiesis
CA2839261A1 (en) 2011-06-13 2012-12-20 Neumedicines, Inc. Mitigation of cutaneous injury with il-12
EP2736530B1 (en) 2011-07-27 2018-06-06 Neumedicines, Inc Use of il-12 to generate endogenous erythropoietin
PL3351261T3 (pl) * 2011-10-11 2021-12-06 Universität Zürich Lek złożony zawierający IL-12 i środek do blokowania cząsteczek hamujących komórki T w terapii nowotworów
US11951157B2 (en) 2011-10-11 2024-04-09 Universitat Zurich Methods of treating malignant tumour with IL-12 and anti-PD-1 antibody
JP2015505326A (ja) 2012-01-18 2015-02-19 ニューメディシンズ，インコーポレーテッド 放射線防護及び放射線誘発性毒性緩和のためのｉｌ−１２
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
CN115916261A (zh) * 2020-04-17 2023-04-04 小利兰·斯坦福大学董事会 工程化il-12和il-23多肽及其用途
EP4228610A1 (en) * 2020-10-13 2023-08-23 Kriya Therapeutics, Inc. Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0629130A1 (en) * 1992-03-04 1994-12-21 Schering Corporation Use of interleukin-10 to suppress graft-vs.-host disease
DE4315127A1 (de) * 1993-05-07 1994-11-10 Behringwerke Ag Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12
US5573764A (en) * 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease

Also Published As

Publication number Publication date
WO1995019786A1 (en) 1995-07-27
DE69526206T2 (de) 2002-11-21
DK0739212T3 (da) 2002-06-03
AU698410B2 (en) 1998-10-29
US5573764A (en) 1996-11-12
CA2181568A1 (en) 1995-07-27
JPH09508371A (ja) 1997-08-26
IL112373A (en) 2006-08-01
ES2179096T3 (es) 2003-01-16
US5756085A (en) 1998-05-26
PT739212E (pt) 2002-08-30
EP0739212A1 (en) 1996-10-30
AU1687595A (en) 1995-08-08
JP3825043B2 (ja) 2006-09-20
ATE215380T1 (de) 2002-04-15
IL112373A0 (en) 1995-03-30
TW349021B (en) 1999-01-01
CA2181568C (en) 2007-09-18
EP0739212B1 (en) 2002-04-03
DE69526206D1 (de) 2002-05-08

Similar Documents

Publication Publication Date Title
ZA95463B (en) Use of interleukin-12 to prevent graft-versus-host disease
SG49658A1 (en) Treatment of condition and disease
HK1015280A1 (en) Use of epinastine in the treatment of pain
EP0441119A3 (en) The use of l-arginine in the treatment of hypertension and other vascular disorders
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
ZA947819B (en) A compress for use in the cold and/or hot treatment of an injury
PH31600A (en) Methods of inhibiting atrophy of the skin and vagina.
ZA931174B (en) Treatment of disease employing hyaluronic acid and nsaids.
EP0651639A4 (en) METHODS OF USING CISAPRIDE (+) FOR THE TREATMENT OF GASTROSOPHAGIC REFLUX AND OTHER DISORDERS.
PL324750A1 (en) Expressive construct p16 and posiibility of using it in treating carcinomas
GB2314273B (en) The use of TCET in the prophylaxis and treatment of allergies
ZA935575B (en) Therapeutic agent and its use.
NO913054D0 (no) Vaginal behandlingsprosess og innretning med dusj.
EP0833641A4 (en) TREATMENT AND PREVENTION OF PROSTATE DISEASES
EP0745597A3 (en) Novel melatonergic indanyl piperazines or homopiperazines
ZA977004B (en) Therapeutic product and its use
GB2230443B (en) Treatment of sleep apnoea
张钦 et al. EJACULATIO DEFICIENS TREATED WITH ACUPUNCTURE REPORT OF 110 CASES
ES2159479A1 (es) Nuevos indazoles como inhibidores de la ciclooxigenasa-ii
ZA963999B (en) 3,4-Disubstituted-phenylsulphonamides and their therapeutic use
ZA964001B (en) 3,4-Disubstituted-phenylsulphonamides and their therapeutic use
ZA963998B (en) 3,4-Disubstituted-phenylsulphonamides and their therapeutic use
EG19049A (en) Solid thiocarbonates and methods of manufacture and use.
GB9312780D0 (en) Therapeutic and cosmetic treatment
GEP19971009B (en) Flupirtine in combination with antiparkinsonica against muscle bracing